However, in the exosome-treated group, the expression levels of TGFβ1 and αSMA were significantly reduced and approached the control and sham rates; this indicates that the administered exosomes reduced the progression of CKD in these rats, and this was also evident in the prominent histological improvements in the kidneys of these rats. Here, TGFB1 is linked to chronic kidney disease.